Armor: September 27, 2000

Archives

Singapore has released more information on its Bionix Infantry Combat Vehicle. The US Army is testing two Bionix in its medium brigade test, along with just about every similar armored vehicle available in the West. Bionix ICV is a further development of the Bionix-25 and the Bionix-40/50 vehicles in full production for the Singapore armed forces. The Bionix-ICV is basically a Bionix-25 with a different turret. The Bionix-25 uses a two-man turret with a 25mm M242 cannon and a 7.62mm machinegun. The Bionix-IBV uses a remotely-controlled weapon station able to mount a 12.7mm machinegun or a Mark-14 automatic 40mm grenade launcher. With this small gun mount instead of an actual turret, the vehicle is lower and lighter, and there is more internal volume increasing the number of troops it can carry. The weapon station has a 27-power zoom daylight television camera, eye-safe laser rangefinder, and ballistic computer and can rotate in a 360-degree arc. The Bionix-ICV can be loaded in a C130 if the 7-tons of appliqu armor is removed, reducing vehicle weight to 17 tons.--Stephen V Cole



 


Article Archive

Armor: Current 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 


X

ad
0
20

Help Keep Us Soaring

We need your help! Our subscription base has slowly been dwindling. We need your help in reversing that trend. We would like to add 20 new subscribers this month.

Each month we count on your subscriptions or contributions. You can support us in the following ways:

  1. Make sure you spread the word about us. Two ways to do that are to like us on Facebook and follow us on Twitter.
  2. Subscribe to our daily newsletter. We’ll send the news to your email box, and you don’t have to come to the site unless you want to read columns or see photos.
  3. You can contribute to the health of StrategyPage. A contribution is not a donation that you can deduct at tax time, but a form of crowdfunding. We store none of your information when you contribute..
Subscribe   Contribute   Close